In this episode, we’re talking about publications impact with Mike Taylor, Head of Data Insights and Grainne Farrell, Manager Corporate Life Science, Central Europe, both at Digital Science.
MAPS speaks with Stefan C. Weiss, MD, Managing Director, Dermatology at OM1 about EMR patient data overlain with technology to create a more accurate and equitable view of post-market safety.
Medical Affairs teams are innovating their approach to engaging patients and empowering people to manage their chronic health conditions. Here, we explore one case study of people living with hidradenitis suppurativa.
In this episode, experts discuss patient-centricity strategies and actions that make patient-first thinking the heart of your organization’s plans.
Based on discussions between 80 cross-industry Field Medical colleagues from small to large biopharmaceutical and medtech companies, this article highlights key actions for Medical Affairs teams to consider for implementation in their own organizations.
In this episode, experts discuss patient-centricity strategies and actions that make patient-first thinking the heart of your organization’s plans.
In this our second episode this season, we’ll be discussing open access in medical publishing from the biopharma perspective.
In this Opening Doors episode of the Medical Affairs Professional Society podcast series, Elevate, we speak with Áine Prendergast, Medical Science Liaison in Oncology with Ipsen.
In today’s episode, our Field Medical experts will discuss tips to understand how you can lead through change.
On today’s episode of the MAPS “Elevate” podcast, we’re discussing the use of Real-World Evidence to understand and possibly intercede in treatment-resistant depression and why is it especially difficult to develop treatments against resistant depression using the traditional structure of R&D-led clinical trials.